A Survey of the Real-world Patient-reported Experience of Follow-up Practices Following Radical Surgery or Radiotherapy for Muscle-invasive Bladder Cancer (MIBC)

被引:0
|
作者
Hack, J. [1 ]
Crabb, S. [1 ]
Costin, M. [2 ]
Kelly, P. [3 ]
Makaroff, L. [2 ]
Douglas, J. [1 ]
机构
[1] Univ Hosp Southampton, Southampton, England
[2] Fight Bladder Canc, Chinnor, England
[3] Act Bladder Canc UK, Tetbury, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E238 / E238
页数:1
相关论文
共 50 条
  • [32] Bladder-sparing trimodality approach for unfit for surgery and cisplatin treatment elderly patients with muscle-invasive bladder cancer (MIBC): results from a monocentric experience
    Rozzi, A.
    Nappa, M.
    Costa, A. M.
    Spigone, B.
    Falbo, P. T.
    Di Nicola, S.
    De Marco, F.
    Corona, M.
    Iannace, A.
    Lanzetta, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [33] Prognostic classification of muscle-invasive bladder cancer (MIBC) following radical cystectomy (RC) alone or with perioperative chemotherapy: Analysis of the US National Cancer Database (NCDB).
    Sonpavde, Guru
    Nelson, Rebecca A.
    Pond, Gregory Russell
    Nix, Jeffrey
    Chennamsetty, Avinash
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [34] Secukinumab significantly improves clinical and patient-reported outcomes up to 18 months of follow-up: Real-world evidence from a US psoriasis registry
    Bagel, Jerry
    Behl, Ajay
    Litman, Heather J.
    Medeiros, Rose A.
    Guo, Ning
    Lebwohl, Mark
    Strober, Bruce
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB152 - AB152
  • [35] PREOPERATIVE RADIOTHERAPY FOR MUSCLE-INVASIVE BLADDER-CARCINOMA - LONG-TERM FOLLOW-UP AND PROGNOSTIC FACTORS FOR 338 PATIENTS
    POLLACK, A
    ZAGARS, GK
    DINNEY, CP
    SWANSON, DA
    VONESCHENBACH, AC
    CANCER, 1994, 74 (10) : 2819 - 2827
  • [36] The role of adjuvant chemotherapy (AC) following radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC): A pooled analysis from phase III studies
    Ruggeri, Enzo M.
    Giannarelli, Diana
    Bria, Emilio
    Carlini, Paolo
    Felici, Alessandra
    Nelli, Fabrizio
    Gallucci, Michele
    Cognetti, Francesco
    Pollera, Camillo F.
    ANNALS OF ONCOLOGY, 2005, 16 : 83 - 84
  • [37] MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer
    Choudhury, Ananya
    Nelson, Louisa D.
    Teo, Mark T. W.
    Chilka, Sameer
    Bhattarai, Selina
    Johnston, Colin F.
    Elliott, Faye
    Lowery, Johanna
    Taylor, Claire F.
    Churchman, Michael
    Bentley, Johanne
    Knowles, Margaret A.
    Harnden, Patricia
    Bristow, Robert G.
    Bishop, D. Timothy
    Kiltie, Anne E.
    CANCER RESEARCH, 2010, 70 (18) : 7017 - 7026
  • [38] REAL WORLD EXPERIENCE WITH EDS-FLU FROM THE PATIENT'S PERSPECTIVE: A FOLLOW-UP PATIENT SURVEY
    O'Connor, M.
    Velez, F.
    McGinnis, J.
    Sacks, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S61 - S61
  • [39] Secukinumab significantly improves disease severity and patient-reported outcomes up to 1 year of follow-up: Real-world analyses from the Corrona Psoriasis Registry
    Bagel, Jerry
    Germino, Rebecca
    Guana, Adriana
    Herrera, Vivian
    Greenberg, Jeffrey D.
    Litman, Heather J.
    Guo, Ning
    Lebwohl, Mark
    Strober, Bruce E.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB122 - AB122
  • [40] Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial
    Huddart, Robert A.
    Hall, Emma
    Lewis, Rebecca
    Porta, Nuria
    Crundwell, Malcolm
    Jenkins, Peter J.
    Rawlings, Christine
    Tremlett, Jean
    Campani, Leila
    Hendron, Carey
    Hussain, Syed A.
    James, Nicholas D.
    EUROPEAN UROLOGY, 2020, 77 (02) : 260 - 268